ESR1 and breast cancer: In another study, an estrogen receptor positive breast cancer cell line made resistant to doxorubicin favored anaplerotic (metabolism involved in replenishing oxaloacetate, a crucial intermediate of the TCA cycle) pyruvate metabolism.